The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“Other commonly used Dyrk1A inhibitors include roscovitine , purvalanol A and epigallocatechin gallate ( EGCG”
Version 1.2 of the Crystallography and NMR system
Brunger, A. T. (2007) · Nature Protocols · doi:10.1038/nprot.2007.406 · Cited by 1,336
Crabtree, G. R., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00699-2 · Cited by 1,323
Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., & Goldsmith, E. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80351-7 · Cited by 729
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Arron, J. R., Winslow, M. M., Polleri, A., Chang, C.-P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., et al. (2006) · Nature · doi:10.1038/nature04678 · Cited by 698
Son, S.-Y., Ma, J., Kondou, Y., Yoshimura, M., Yamashita, E., & Tsukihara, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710626105 · Cited by 623
Sherman, S. L., Allen, E. G., Bean, L. H., & Freeman, S. B. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20157 · Cited by 529
Korbel, J. O., Tirosh-Wagner, T., Urban, A. E., Chen, X.-N., Kasowski, M., Dai, L., Grubert, F., Erdman, C., Gao, M. C., Lange, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813248106 · Cited by 399
A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT
Gwack, Y., Sharma, S., Nardone, J., Tanasa, B., Iuga, A., Srikanth, S., Okamura, H., Bolton, D., Feske, S., Hogan, P. G., et al. (2006) · Nature · doi:10.1038/nature04631 · Cited by 397
Altafaj, X. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1915 · Cited by 396
WOODS, Y. L., COHEN, P., BECKER, W., JAKES, R., GOEDERT, M., WANG, X., & PROUD, C. G. (2001) · Biochemical Journal · doi:10.1042/bj3550609 · Cited by 342
Fotaki, V., Dierssen, M., Alcántara, S., Martínez, S., Martí, E., Casas, C., Visa, J., Soriano, E., Estivill, X., & Arbonés, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6636-6647.2002 · Cited by 338
Smith, D. J., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., O'Dell, T. J., Fung, J., Weier, H.-U. G., Cheng, J.-F., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-28 · Cited by 321
Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks
Muraki, M., Ohkawara, B., Hosoya, T., Onogi, H., Koizumi, J., Koizumi, T., Sumi, K., Yomoda, J.-I., Murray, M. V., Kimura, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314298200 · Cited by 308
Self-citationBecker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., & Joost, H.-G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25893 · Cited by 285
DYRK1A-mediated Hyperphosphorylation of Tau
Ryoo, S.-R., Jeong, H. K., Radnaabazar, C., Yoo, J.-J., Cho, H.-J., Lee, H.-W., Kim, I.-S., Cheon, Y.-H., Ahn, Y. S., Chung, S.-H., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707358200 · Cited by 283
Kimura, R., Kamino, K., Yamamoto, M., Nuripa, A., Kida, T., Kazui, H., Hashimoto, R., Tanaka, T., Kudo, T., Yamagata, H., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl437 · Cited by 281
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
Göckler, N., Jofre, G., Papadopoulos, C., Soppa, U., Tejedor, F. J., & Becker, W. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07346.x · Cited by 278
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in down syndrome
Liu, F., Liang, Z., Wegiel, J., Hwang, Y., Iqbal, K., Grundke‐Iqbal, I., Ramakrishna, N., & Gong, C. (2008) · The FASEB Journal · doi:10.1096/fj.07-104539 · Cited by 272
Inhibition of Monoamine Oxidase A by β-Carboline Derivatives
Kim, H., Sablin, S. O., & Ramsay, R. R. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9771 · Cited by 253
Down syndrome--recent progress and future prospects
Wiseman, F. K., Alford, K. A., Tybulewicz, V. L. J., & Fisher, E. M. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp010 · Cited by 248
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions
Yu, T., Li, Z., Jia, Z., Clapcote, S. J., Liu, C., Li, S., Asrar, S., Pao, A., Chen, R., Fan, N., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq179 · Cited by 237
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Fukuhara, T., Hosoya, T., Shimizu, S., Sumi, K., Oshiro, T., Yoshinaka, Y., Suzuki, M., Yamamoto, N., Herzenberg, L. A., Herzenberg, L. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604616103 · Cited by 231
Self-citationMandel, S. A., Amit, T., Weinreb, O., Reznichenko, L., & Youdim, M. B. H. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00060.x · Cited by 221
DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects
Ahn, K.-J., Jeong, H. K., Choi, H.-S., Ryoo, S.-R., Kim, Y. J., Goo, J.-S., Choi, S.-Y., Han, J.-S., Ha, I., & Song, W.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.006 · Cited by 220
Calcineurin/NFAT Signaling Is Required for Neuregulin-Regulated Schwann Cell Differentiation
Kao, S.-C., Wu, H., Xie, J., Chang, C.-P., Ranish, J. A., Graef, I. A., & Crabtree, G. R. (2009) · Science · doi:10.1126/science.1166562 · Cited by 218
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Guedj, F., Sébrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., Smith, D., Rubin, E., Gillet, B., Arbones, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004606 · Cited by 216
Guimera, J. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.9.1305 · Cited by 215
Himpel, S., PANZER, P., EIRMBTER, K., Czajkowska, H., Sayed, M., Packman, L. C., Blundell, T. L., Kentrup, H., Grötzinger, J., Joost, H., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590497 · Cited by 209
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with down syndrome
Dowjat, W. K., Adayev, T., Kuchna, I., Nowicki, K., Palminiello, S., Hwang, Y. W., & Wegiel, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.026 · Cited by 190
Guimera, J., Casas, C., Estivill, X., & Pritchard, M. (1999) · Genomics · doi:10.1006/geno.1999.5775 · Cited by 186
Ferrer, I., Barrachina, M., Puig, B., Martínez de Lagrán, M., Martí, E., Avila, J., & Dierssen, M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.020 · Cited by 178
Olson, L. E., Roper, R. J., Sengstaken, C. L., Peterson, E. A., Aquino, V., Galdzicki, Z., Siarey, R., Pletnikov, M., Moran, T. H., & Reeves, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm022 · Cited by 178
Song, W.-J., Sternberg, L. R., Kasten-Sportès, C., Keuren, M. L. V., Chung, S.-H., Slack, A. C., Miller, D. E., Glover, T. W., Chiang, P.-W., Lou, L., et al. (1996) · Genomics · doi:10.1006/geno.1996.0636 · Cited by 176
The challenge of Down syndrome
Antonarakis, S. E., & Epstein, C. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.08.005 · Cited by 139
The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
Laguna, A., Aranda, S., Barallobre, M. J., Barhoum, R., Fernández, E., Fotaki, V., Delabar, J. M., de la Luna, S., de la Villa, P., & Arbonés, M. L. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.10.014 · Cited by 137
Shindoh, N., Kudoh, J., Maeda, H., Yamaki, A., Minoshima, S., Shimizu, Y., & Shimizu, N. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1135 · Cited by 120
Węgiel, J., Dowjat, K., Kaczmarski, W., Kuchna, I., Nowicki, K., Frackowiak, J., Mazur‐Kolecka, B., Wegiel, J., Silverman, W. P., Reisberg, ., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0419-6 · Cited by 119
Patra, S. K., Rizzi, F., Silva, A., Rugină, D. O., & Bettuzzi, S. (2008) · PubMed · Cited by 103
Arqué, G., Fotaki, V., Fernández, D., de Lagrán, M. M., Arbonés, M. L., & Dierssen, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002575 · Cited by 99
Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/− mouse
Benavides‐Piccione, R., Dierssen, M., Ballesteros‐Yáñez, I., de Lagrán, M. M., Arbonés, M. L., Fotaki, V., DeFelipe, J., & Elston, G. N. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.004 · Cited by 98
An investigation on the central effects of harmine, harmaline and related β-carbolines
Fuentes, J. A., & Longo, V. G. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90004-9 · Cited by 97
Branchi, I., Bichler, Z., Minghetti, L., Delabar, J. M., Malchiodi‐Albedi, F., Gonzalez, M.-C., Chettouh, Z., Nicolini, A., Chabert, C., Smith, D., et al. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.429 · Cited by 97
Cloning and Characterization of DYRK1B, a Novel Member of the DYRK Family of Protein Kinases
Leder, S., Weber, Y. G., Altafaj, X., Estivill, X., Joost, H., & Becker, W. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9967 · Cited by 83
Molecular basis of pharmacotherapies for cognition in Down syndrome
Gardiner, K. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.010 · Cited by 81
de Lagrán, M. M., Altafaj, X., Gallego, X., Martí, E., Estivill, X., Sahún, I., Fillat, C., & Dierssen, M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.002 · Cited by 81
Mott, B. T., Tanega, C., Shen, M., Maloney, D. J., Shinn, P., Leister, W., Marugán, J., Inglese, J., Austin, C. P., Misteli, T., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.121 · Cited by 77
Fotaki, V., de Lagrán, M. M., Estivill, X., Arbonés, M. L., & Dierssen, M. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.4.815 · Cited by 73
Involvement of NLK and Sox11 in neural induction in Xenopus development
Hyodo‐Miura, J., Urushiyama, S., Nagai, S., Nishita, M., Ueno, N., & Shibuya, H. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00536.x · Cited by 61
Self-citationLeder, S., Czajkowska, H., Maenz, B., de Graaf, K., Barthel, A., Joost, H., & Becker, W. B. (2003) · Biochemical Journal · doi:10.1042/bj20030182 · Cited by 60
Noll, C., Planque, C., Ripoll, C., Guedj, F., Díez-Betriu, A., Ducros, V., Belin, N., Duchon, A., Paul, J., Badel, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007540 · Cited by 54
Altafaj, X., Ortiz-Abalia, J., Fernández, M., Potier, M., Laffaire, J., Andreu, N., Dierssen, M., González-García, C., Ceña, V., Martí, E., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.024 · Cited by 40
Increased Dosage of DYRK1A and Brain Volumetric Alterations in a YAC Model of Partial Trisomy 21
Sebrié, C., Chabert, C., Ledru, A., Guedj, F., Po, C., Smith, D., Rubin, E. M., Rivals, I., Belœil, J., Gillet, B., et al. (2008) · The Anatomical Record · doi:10.1002/ar.20640 · Cited by 23
Satoh, K., Ohnishi, J., Sato, A., Takeyama, M., Iemura, S., Natsume, T., & Shibuyà, H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01481-07 · Cited by 22
Cited by
Wang, P., Alvarez-Perez, J.-C., Felsenfeld, D. P., Liu, H., Sivendran, S., Bender, A., Kumar, A., Sanchez, R., Scott, D. K., Garcia-Ocaña, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3820 · Cited by 404
Duchon, A., & Herault, Y. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00104 · Cited by 181
Atas-Ozcan, H., Brault, V., Duchon, A., & Herault, Y. (2021) · Genes · doi:10.3390/genes12111833 · Cited by 78
Neumann, F., Gourdain, S., Albac, C., Dekker, A. D., Bui, L. C., Dairou, J., Schmitz-Afonso, I., Hue, N., Rodrigues-Lima, F., Delabar, J. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20984-z · Cited by 71
Wu, Y.-W., HuangFu, W.-C., Lin, T. E., Peng, C.-H., Tu, H.-J., Sung, T.-Y., Sung, T.-Y., Yen, S.-C., Pan, S.-L., & Hsu, K.-C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.129074 · Cited by 15
Metadata
- Authors
- Ogawa, Y., Nonaka, Y., Goto, T., Ohnishi, E., Hiramatsu, T., Kii, I., Yoshida, M., Ikura, T., Onogi, H., Shibuya, H., Hosoya, T., Ito, N., & Hagiwara, M.
- Venue
- Nature Communications
- Published
- 2010-10-05
- Volume
- 1
- Issue
- 1
- Pages
- 86-86
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2168175722
- Cited by
- 276
- References
- 58
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.